banner ad
banner ad

August, 2009

Do You have a YouTube Channel for your MedSpa?

August 26, 2009 | 0

The fact is people love multimedia, according to MediaWeek, rich media ads that featured video excelled in most branding categories, including awareness, brand favorability and purchase intent.  It’s easy to see why, since most people have access to high speed internet at home and work, in addition to their iPhones and Blackberry’s. Creating video content […]

Read More

Minimally Invasive Cosmetic Procedures Should Not Be Taken Lightly

August 19, 2009 | 0

Dermatologists urge patients to ask questions to ensure safety of procedure  Today, there are more ways than ever before to “get a little work done.” From skin fillers to fat-reduction procedures, the options are endless for those looking to improve their appearance and boost their self-esteem. But with so many physicians and options from which […]

Read More

Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort

August 18, 2009 | 0

The first FDA-approved injectable dermal filler to combine hyaluronic acid and lidocaine, a local anesthetic that improves patient comfort, and provides physicians with a new alternative for their aesthetic practice. Designed, developed and manufactured by Anika Therapeutics, hydrelle is formulated for durability based on its proprietary cross-linking technology and the highest concentration of hyaluronic acid. […]

Read More

Meal Replacements Aid Weight Loss, Study Finds

August 13, 2009 | 0

Meal replacements in a medically supervised weight loss program are successful in facilitating weight loss, according to a new study conducted at the University of Kentucky. The study appears in the August 2009 issue of the Journal of the American Dietetic Association. The meal replacements are products of Health Management Resources Corporation (HMR), a privately […]

Read More

Is Allergan’s Latisse Also a Cure for Baldness?

August 12, 2009 | 0

Allergan believes it may have a cure for baldness in the form of Latisse/Lumigan, its glaucoma drug-cum-eyelash enhancer. EVP R&D Scott Whitcup told investors on Allergan’s Q2 2009 conference call: We’re in the midst of looking at a number of [selections] by Bimatoprost [the chemical name for Latisse and Lumigan] for hair growth on the […]

Read More

Topical toxin appears to be promising in phase II data

August 11, 2009 | 2

NEW YORK – A topical, noninjectable form of botulinum toxin asserted its ability to effectively treat crow’s feet through impressive data from a recently completed phase II clinical trial released here.   Seventy-five patients at four study sites were treated with the novel topical toxin or placebo to the crow’s feet area. On a four-point […]

Read More

Facial surgery: Anatomy demands constant attention

August 11, 2009 | 0

La Jolla, Calif. — To paraphrase English surgeon and anatomist Sir Ashley Paston Cooper, the best surgeon is the one who makes the fewest mistakes. For dermatologic surgeons, minimizing mistakes means always being aware of underlying facial anatomy, says Hugh T. Greenway, M.D., chairman, Division of Procedural Dermatology, Scripps Clinic, La Jolla, Calif. “The rest […]

Read More

Popularity of the peel: Chemical ablation retains place in derm armamentarium

August 11, 2009 | 0

Atlanta — Despite an explosion of skin-resurfacing options, including devices highly promoted to consumers by manufacturers, the tried-and-true chemical peel remains one of the most performed cosmetic surgeries on women. The rate of popularity growth for the chemical peel is not what it was in the 1990s, but unrivaled dramatic results and a good safety […]

Read More

Information for Healthcare Professionals: Botox/Botox Cosmetic, Dysport and Myobloc

August 5, 2009 | 0

FDA ALERT [08/2009]: As announced on April 30, 2009, based on a safety evaluation of the botulinum toxin products, FDA has concluded that the prescribing information for OnabotulinumtoxinA (marketed as Botox/Botox Cosmetic) and RimabotulinumtoxinB (marketed as Myobloc) must be updated to ensure their continued safe use.  On July 31, 2009, FDA, under the authorities granted […]

Read More

Noninvasive Approaches Target Fat

August 4, 2009 | 0

When it comes to noninvasive fat removal, a plethora of technologies promise to trim fat from pesky problem areas, such as the hips, thighs and buttocks. But questions loom large, as many noninvasive technologies await regulatory approvals. “Noninvasive fat removal is now a reality,” says Matthew Avram, MD, who presented on New Frontiers in Noninvasive Fat […]

Read More

banner ad
banner ad